Literature DB >> 34882443

How bad is Omicron? Some clues are emerging.

Kai Kupferschmidt, Gretchen Vogel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34882443     DOI： 10.1126/science.acx9782

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  22 in total

1.  SARS-CoV-2 prefusion spike protein stabilized by six rather than two prolines is more potent for inducing antibodies that neutralize viral variants of concern.

Authors:  Mijia Lu; Michelle Chamblee; Yuexiu Zhang; Chengjin Ye; Piyush Dravid; Jun-Gyu Park; K C Mahesh; Sheetal Trivedi; Satyapramod Murthy; Himanshu Sharma; Cole Cassady; Supranee Chaiwatpongsakorn; Xueya Liang; Jacob S Yount; Prosper N Boyaka; Mark E Peeples; Luis Martinez-Sobrido; Amit Kapoor; Jianrong Li
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-22       Impact factor: 12.779

Review 2.  Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants.

Authors:  Cong Sun; Chu Xie; Guo-Long Bu; Lan-Yi Zhong; Mu-Sheng Zeng
Journal:  Signal Transduct Target Ther       Date:  2022-06-28

3.  Immune responses in Omicron SARS-CoV-2 breakthrough infection in vaccinated adults.

Authors:  Ludvig A Munthe; Siri Mjaaland; Hassen Kared; Asia-Sophia Wolf; Amin Alirezaylavasani; Anthony Ravussin; Guri Solum; Trung The Tran; Fridtjof Lund-Johansen; John Torgils Vaage; Lise Sofie Nissen-Meyer; Unni C Nygaard; Olav Hungnes; Anna H Robertson; Lisbeth Meyer Næss; Lill Trogstad; Per Magnus
Journal:  Nat Commun       Date:  2022-07-18       Impact factor: 17.694

4.  SARS-CoV-2 Omicron variant causes mild pathology in the upper and lower respiratory tract of hamsters.

Authors:  Federico Armando; Georg Beythien; Franziska K Kaiser; Malgorzata Ciurkiewicz; Albert D M E Osterhaus; Wolfgang Baumgärtner; Lisa Allnoch; Laura Heydemann; Malgorzata Rosiak; Svenja Becker; Mariana Gonzalez-Hernandez; Mart M Lamers; Bart L Haagmans; Kate Guilfoyle; Geert van Amerongen
Journal:  Nat Commun       Date:  2022-06-20       Impact factor: 17.694

5.  [Strengthening the prevention and treatment of Omicron infection in children].

Authors:  Fu-Yong Jiao; Lei Ma
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-04-15

6.  The Emergence of the Omicron (B.1.1.529) SARS-CoV-2 Variant: What is the Impact on the Continued Pandemic?

Authors:  Jaffar A Al-Tawfiq; Van-Thuan Hoang; Nhat Le Bui; Dinh-Toi Chu; Ziad A Memish
Journal:  J Epidemiol Glob Health       Date:  2022-01-28

7.  The SARS-CoV-2 B.1.1.529 Omicron virus causes attenuated infection and disease in mice and hamsters.

Authors:  Michael Diamond; Peter Halfmann; Tadashi Maemura; Kiyoko Iwatsuki-Horimoto; Shun Iida; Maki Kiso; Suzanne Scheaffer; Tamarand Darling; Astha Joshi; Samantha Loeber; Stephanie Foster; Baoling Ying; Bradley Whitener; Katharine Floyd; Michiko Ujie; Noriko Nakajima; Mutsumi Ito; Ryan Wright; Ryuta Uraki; Rong Li; Yuko Sakai; Yanan Liu; Deanna Larson; Jorge Osorio; Juan Hernandez-Ortiz; Karl Čiuoderis; Kelsey Florek; Mit Patel; Allen Bateman; Abby Odle; Lok-Yin Wong; Zhongde Wang; Venkata Viswanadh Edara; Zhenlu Chong; Larissa Thackray; Hiroshi Ueki; Seiya Yamayoshi; Masaki Imai; Stanley Perlman; Richard Webby; Robert Seder; Mehul Suthar; Adolfo Garcia-Sastre; Michael Schotsaert; Tadaki Suzuki; Adrianus Boon; Yoshihiro Kawaoka; Daniel Douek; Juan Moliva; Nancy Sullivan; Matthew Gagne; Amy Ransier; James Case; Trushar Jeevan; John Franks; Thomas Fabrizio; Jennifer DeBeauchamp; Lisa Kercher; Patrick Seiler; Gagandeep Singh; Prajakta Warang; Ana S Gonzalez-Reiche; Emilia Sordillo; Harm van Bakel; Viviana Simon
Journal:  Res Sq       Date:  2021-12-29

Review 8.  Omicron variant (B.1.1.529) of SARS-CoV-2: Mutation, infectivity, transmission, and vaccine resistance.

Authors:  Shi-Yan Ren; Wen-Biao Wang; Rong-Ding Gao; Ai-Mei Zhou
Journal:  World J Clin Cases       Date:  2022-01-07       Impact factor: 1.337

Review 9.  Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic.

Authors:  Rekha Khandia; Shailja Singhal; Taha Alqahtani; Mohammad Amjad Kamal; Nahed A El-Shall; Firzan Nainu; Perumal Arumugam Desingu; Kuldeep Dhama
Journal:  Environ Res       Date:  2022-01-29       Impact factor: 8.431

Review 10.  SARS-CoV-2 reinfections: Overview of efficacy and duration of natural and hybrid immunity.

Authors:  Stefan Pilz; Verena Theiler-Schwetz; Christian Trummer; Robert Krause; John P A Ioannidis
Journal:  Environ Res       Date:  2022-02-08       Impact factor: 8.431
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.